| Ilka C Naumann, MD | |
|
30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 | |
| (248) 865-4444 | |
| (248) 865-6161 |
| Full Name | Ilka C Naumann |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 22 Years |
| Location | 30055 Northwestern Hwy, Farmington Hills, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568620599 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Ear Institute Pllc | 5597735514 | 30 |
| Vhs Physicians Of Michigan | 8921289760 | 217 |
News Archive
A research paper published in 1998, which claimed the MMR jab was in some way linked to autism and Crohn's disease, the inflammatory bowel disease, caused MMR vaccination numbers to fall across the country.
During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Viking Systems, Inc. announced today that it will present its Next Generation 3DHD technology at the 5th International Symposium on Hybrid Approach to Congenital Heart Disease (ISHAC) from August 31 - September 2, 2010 in Columbus, Ohio.
› Verified 6 days ago
| Entity Name | Michigan Ear Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568575215 PECOS PAC ID: 5597735514 Enrollment ID: O20040728000359 |
News Archive
A research paper published in 1998, which claimed the MMR jab was in some way linked to autism and Crohn's disease, the inflammatory bowel disease, caused MMR vaccination numbers to fall across the country.
During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Viking Systems, Inc. announced today that it will present its Next Generation 3DHD technology at the 5th International Symposium on Hybrid Approach to Congenital Heart Disease (ISHAC) from August 31 - September 2, 2010 in Columbus, Ohio.
› Verified 6 days ago
| Entity Name | Vhs Physicians Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073827101 PECOS PAC ID: 8921289760 Enrollment ID: O20110225000849 |
News Archive
A research paper published in 1998, which claimed the MMR jab was in some way linked to autism and Crohn's disease, the inflammatory bowel disease, caused MMR vaccination numbers to fall across the country.
During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Viking Systems, Inc. announced today that it will present its Next Generation 3DHD technology at the 5th International Symposium on Hybrid Approach to Congenital Heart Disease (ISHAC) from August 31 - September 2, 2010 in Columbus, Ohio.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ilka C Naumann, MD 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Ph: (248) 865-4444 | Ilka C Naumann, MD 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Ph: (248) 865-4444 |
News Archive
A research paper published in 1998, which claimed the MMR jab was in some way linked to autism and Crohn's disease, the inflammatory bowel disease, caused MMR vaccination numbers to fall across the country.
During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Viking Systems, Inc. announced today that it will present its Next Generation 3DHD technology at the 5th International Symposium on Hybrid Approach to Congenital Heart Disease (ISHAC) from August 31 - September 2, 2010 in Columbus, Ohio.
› Verified 6 days ago
Casey Ashby, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 28080 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-471-8000 | |
Anuja Dharap, Otolaryngology Medicare: Medicare Enrolled Practice Location: 35630 Grand River Ave Apt 217, Farmington Hills, MI 48335 Phone: 716-495-9800 | |
Dr. Dennis I Bojrab, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 Fax: 248-865-6161 | |
Dr. Michael J Larouere, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 Fax: 248-865-6161 | |
Dr. Eric W Sargent, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 Fax: 248-865-6161 | |
Dr. Alice D Lee, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 | |
Robert S Hong, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4135 Fax: 248-865-6161 |